InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LPS-EB VacciGrade™ | Suppression of lipopolysaccharide-induced corneal opacity by hepatocyte growt... | 2022 | Sci Rep | Elbasiony E. et al. | DOI: 10.1038/s41598-021-04418-x |
Blasticidin | Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNB... | 2022 | Cell Death Dis. | Al Haq A.T. et al. | DOI: 10.1038/s41419-021-04486-x |
G418 (Geneticin) | A new transgene mouse model using an extravesicular EGFP tag enables affinity... | 2022 | Sci Rep | Norgard M.O. et al. | DOI: 10.1038/s41598-021-04512-0 |
Puromycin | The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor sup... | 2022 | Commun Biol | Machino H. et al. | DOI: 10.1038/s42003-021-02992-4 |
Imiquimod (R837) | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
FSL-1 | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
MDP | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
R848 (Resiquimod) | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
ODN 2395 - TLR9 ligand | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
Pam3CSK4 | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
Normocin® - Antimicrobial Reagent | ATRX loss in glioma results in dysregulation of cell-cycle phase transition a... | 2022 | Cell Rep | Qin T. et al. | DOI: 10.1016/j.celrep.2021.110216 |
Quil-A® adjuvant | Mannose-binding lectin and complement mediate follicular localization and enh... | 2022 | Cell Rep | Read B.J. etal. | DOI: 10.1016/j.celrep.2021.110217 |
ISD | Reprogramming of nucleotide metabolism by interferon confers dependence on th... | 2022 | Cell Rep | Abt E.R. et al. | DOI: 10.1016/j.celrep.2021.110236 |
2’3’-cGAM(PS)2 (Rp/Sp) | Reprogramming of nucleotide metabolism by interferon confers dependence on th... | 2022 | Cell Rep | Abt E.R. et al. | DOI: 10.1016/j.celrep.2021.110236 |
Puromycin | A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoti... | 2022 | Nat Commun | Pradella D. et al. | DOI: 10.1038/s41467-021-24998-6 |
PlasmoTest™ - Mycoplasma Detection Kit | A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protec... | 2022 | Mol Ther | Bliss C.M. et al. | DOI: 10.1016/j.ymthe.2022.01.011 |
Plasmocin® - Mycoplasma Elimination Reagent | Sensing plasma membrane pore formation induces chemokine production in surviv... | 2022 | Dev Cell | Wang W. et al. | DOI: 10.1016/j.devcel.2021.12.015 |
Poly(I:C) HMW | Adaptive differentiation promotes intestinal villus recovery. | 2022 | Dev Cell | Ohara T.E. et al. | DOI: 10.1016/j.devcel.2021.12.012 |
Primocin® | Accumulation of APP-CTF induces mitophagy dysfunction in the iNSCs model of A... | 2022 | Cell Death Discov | Lee S.E. et al. | DOI: 10.1038/s41420-021-00796-3 |
HeLa-Difluo™ hLC3 Cells | Robust LC3B lipidation analysis by precisely adjusting autophagic flux. | 2022 | Sci Rep | Liebl M.P. et al. | DOI: 10.1038/s41598-021-03875-8 |